Categories

Cannabidiol promoters warned

Posted 10 April 2019

The Federal Trade Commission (FTC) and the U.S. Food and Drug Administration (FDA) have jointly sent warning letters to Nutra Pure LLC, PotNetwork Holdings, Inc., and Advanced Spine and Pain, LLC (d/b/a Relievus) because they believe the companies are illegally marketing products containing cannabidiol (CBD) to treat a variety of serious diseases and conditions.

[FTC joins FDA in sending warning letters to companies advertising and selling products containing cannabidiol (CBD) claiming to treat Alzheimer’s, cancer, and other diseases. FTC Press Release. April 2, 2019]

https://www.ftc.gov/news-events/press-releases/2019/04/ftc-joins-fda-sending-warning-letters-companies-advertising

CBD is a chemical compound found in marijuana and hemp that does not produce a high. In 2018, the FDA approved a cannabidiol preparation (brand name Epidiolex) to treat two rare, severe forms of epilepsy. But since 2015, the FDA has ordered many companies to stop making unapproved claims.

https://www.fda.gov/NewsEvents/PublicHealthFocus/ucm484109.htm

The market for unapproved CBD products is nevertheless burgeoning, as consumer Read the rest

CBD Is Everywhere, but Scientists Still Don’t Know Much About It

Posted 07 March 2019

It’s worth reflecting on these statements: “It is a kind of a new snake oil in the sense that there are a lot of claims and not so much evidence”, and “People are making it out to be a nirvana kind of drug, and that’s a problem. One compound cannot cure everything.”

CBD Is Everywhere, but Scientists Still Don’t Know Much About It

“It is a kind of a new snake oil in the sense that there are a lot of claims and not so much evidence,” said one expert.

By Roni Caryn Rabin Feb. 25, 2019

New York Times

Cannabidiol, or CBD, a nonintoxicating component of the marijuana plant, is touted as a magic bullet that eases pain, anxiety, insomnia and depression. Salves, sprays, tinctures and oils containing CBD are marketed as aphrodisiacs that boost desire; as balms for eczema, pimples and hot flashes; and Read the rest

Cannabis health products are everywhere – but do they live up to the hype?

Posted 17 October 2018

Cannabidiol, or CBD, is now available in the UK in everything from skin creams to beers. But don’t set your hopes too high

Amy Fleming Mon 15 Oct 2018 The Guardian

This has been the year medical cannabis hit the mainstream. The government has announced that it is relaxing laws on when cannabis medicines can be prescribed by doctors, following high-profile cases such as that of Billy Caldwell, the 13-year-old boy hospitalised by his epileptic seizures after he was denied legal access to the cannabis oil that helps control them. Meanwhile a new generation of cannabis medicines has shown great promise (both anecdotally and in early clinical trials) in treating a range of ills from anxiety, psychosis and epilepsy to pain, inflammation and acne. And you don’t have to get stoned to reap the health benefits.

Read the rest

Medicinal cannabis products: Patient information

Posted 30 May 2018

The Australian TGA (Therapeutic Goods Administration) has published the following patient information guide.

In South Africa, an application in terms of s22A(9) is needed for exceptional access to THC-containing preparations for research or treatment, and a s21 application needed for access to unregistered THC (S6 when intended for therapeutic purposes) or CBD (S4 when intended for therapeutic purposes) preparations. 

Medicinal cannabis products: Patient information

29 May 2018               

Over the past few years there has been increased interest from Australians in the use of cannabis for medicinal purposes. Commonwealth, state and territory governments have used existing laws or passed specific laws to allow the prescribing and dispensing of medicinal cannabis products, as well as cannabis cultivation and manufacture for medicinal purposes.

Read the rest

FDA Pursues Unproven Cancer Claims

Posted 21 December 2017

December 19, 2017

FDA Pursues Unproven Cancer Claims

Rebecca Voelker, MSJ

JAMA.  2017;318(23):2288. doi:10.1001/jama.2017.19150

Four companies have received FDA warning letters for selling products online that agency officials said made unproven anticancer claims and contained a component of the marijuana plant.

The products reportedly contained cannabidiol (CBD), which isn’t FDA approved for any indication. Such products are marketed in a variety of forms including oil drops, capsules, syrup, tea, and topical lotion or cream. Selling unapproved products with unsubstantiated therapeutic claims violates the federal Food, Drug, and Cosmetic Act and could harm patients, according to FDA officials.

Claims made on web pages, online stores, and social media touted the products’ abilities to combat tumor and cancer cells, make cancer cells “commit suicide” without killing other cells, and inhibit cell division and growth in certain types of cancer. Some of the products also were marketed as alternative Read the rest

A deadly plague of cannabis oil pedlars

Posted o3 February 2017

An interesting perspective on cannabis oil, written by Igo Vegter, and published in the Daily Maverick.

Some extracts:

[note note_color=”#fbfbf1″]“Cannabis ought to be legal. It ought to be researched for its medicinal qualities. But people who sell homemade cures for cancer are dangerous, swindling desperate people into forgoing medical treatment in favour of unproven home remedies. The price, too often, is death.”[/note]

[note note_color=”#fbfbf1″]”Even highly intelligent people succumb to desperation when facing a dreaded diagnosis. It is not pleasant to hear that you have a disease without a certain cure, or that you have a 50% chance of dying in the next five years. When the prognosis is even worse, as it can be with certain types of cancer or with late diagnoses, it is hardly surprising that people lose faith in conventional medicine, or are prepared to try anything, however outlandish. When Read the rest